1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Obesity Medication Manufacturing in the US - Industry Market Research Report


Obesity Medication Manufacturing


The industry is growing along with Americans' waistlines. While the industry has benefited from rising obesity rates and other demographic trends, regulatory approval of its drugs determines the success of its operators. During the past five years, revenue fell due to the declines associated with the withdrawal of Abbott Laboratories' Meridia from the market. Nevertheless, over the long term, the industry will experience rising demand for these drugs as the population becomes increasingly obese and consumers have more money available to spend on obesity medication.
This industry manufactures medication that is used to treat obesity. The FDA has approved long-term and short-term drugs for the long-term treatment of obesity. Diet supplements are not included in this industry.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Table Of Contents

Obesity Medication Manufacturing in the US - Industry Market Research Report
TABLE OF CONTENTS

ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources

INDUSTRY AT A GLANCE

INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle

PRODUCTS and MARKETS
Supply Chain
Products and Services
Demand Determinants
Major Markets
International Trade
Business Locations

COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization

MAJOR COMPANIES

OPERATING CONDITIONS
Capital Intensity
Technology and Systems
Revenue Volatility
Regulation and Policy
Industry Assistance

KEY STATISTICS
Industry Data
Annual Change
Key Ratios

JARGON and GLOSSARY




MAJOR COMPANIES

GlaxoSmithKline PLC

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

  • $ 4995
  • Industry report
  • August 2016
  • by GBI Research

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment Summary Diabetes is a chronic metabolic disease ...

Obesity Treatment Market Size & Forecast, By Drugs, By Surgery & Devices And Trend Analysis To 2024

Obesity Treatment Market Size & Forecast, By Drugs, By Surgery & Devices And Trend Analysis To 2024

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The global obesity treatment market is expected to reach USD 15.6 billion by 2024, according to a new report by Grand View Research, Inc. Upward trend in sedentary lifestyles, physical inactivity, and ...

Global Intragastric Balloons Market - Strategic Assessment and Forecast Till 2021

Global Intragastric Balloons Market - Strategic Assessment and Forecast Till 2021

  • $ 2995
  • Industry report
  • October 2016
  • by Beige Market Intelligence

The global intragastric balloons market is expected to grow at a CAGR of more than 7.01% till 2021. Global Intragastric Balloons Market - Strategic Assessment and Forecast till 2021 market research report ...

Obesity-api Insights, 2016

November 2016 $ 1250

Download Unlimited Documents from Trusted Public Sources

Mental Health Statistics in the UK

  • November 2016
    11 pages
  • Antipsychotic  

  • United Kingdom  

View report >

Cardiovascular Disease Statistics in the UK

  • November 2016
    7 pages
  • Cardiovascular ...  

  • United Kingdom  

View report >

Obesity Statistics in the US

  • November 2016
    40 pages
  • Obesity  

    Vaccine  

  • United States  

    North America  

    World  

View report >

Related Market Segments :

Obesity

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.